Thu, February 29, 2024

Andrea Tan Maintained (TARS) at Hold with Increased Target to $30 on, Feb 29th, 2024

Andrea Tan of Goldman Sachs, Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Hold with Increased Target from $19 to $30 on, Feb 29th, 2024.

Andrea has made no other calls on TARS in the last 4 months.



There are 3 other peers that have a rating on TARS. Out of the 3 peers that are also analyzing TARS, 0 agree with Andrea's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrea


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $50 on, Wednesday, February 28th, 2024
  • Francois Brisebois of "Oppenheimer" Reiterated at Buy with Increased Target to $59 on, Wednesday, February 28th, 2024
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $57 on, Wednesday, February 28th, 2024